Tag: Biomarker Testing Market 2025

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Market Value Trend Is Expected For The Biomarker Testing Market From 2026 To 2030?

The biomarker testing market size has seen rapid growth in recent years. It is anticipated to expand from $19.75 billion in 2025 to $22.26 billion in 2026, at a compound annual growth rate (CAGR) of 12.7%. The growth observed in the historic period can be attributed to the increasing prevalence of chronic diseases, the expansion of clinical research activities, the rising adoption of molecular diagnostics, the growing demand for targeted therapies, and the availability of advanced testing platforms.

The biomarker testing market is projected for significant expansion in the coming years. By 2030, this market is anticipated to reach $35.51 billion, expanding at a compound annual growth rate (CAGR) of 12.4%. This projected growth is driven by several factors, including heightened investments in personalized medicine, the escalating application of biomarkers in drug development, the broadening scope of oncology and infectious disease testing, an increasing need for less invasive diagnostic methods, and progress in multi-omics technologies. Key trends anticipated during this period encompass the growing acceptance of precision medicine diagnostics, an uptick in the utilization of companion diagnostics, the expanding incorporation of AI in biomarker analysis, the increased prevalence of liquid biopsy testing, and a greater emphasis on identifying diseases at earlier stages.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24480&type=smp

Which Major Factors Are Contributing To The Development Of The Biomarker Testing Market?

The increasing burden of cancer is anticipated to drive the expansion of the biomarker testing market. Cancer encompasses a range of diseases marked by the uncontrolled multiplication and spread of abnormal cells within the body. This rising cancer prevalence is attributable to lifestyle factors such as poor nutrition, smoking, insufficient physical activity, and excessive alcohol consumption. Biomarker testing enhances cancer detection by enabling the early and precise identification of disease-specific markers, thereby improving diagnostic accuracy. It also facilitates personalized treatment strategies, leading to improved patient outcomes and more efficient healthcare management. As an illustration, in July 2024, the Australian Institute of Health and Welfare, an Australia-based government agency, reported that around 165,000 new cancer cases were identified in 2023, with forecasts predicting approximately 204,000 cases annually by 2033, leading to an estimated total of 1.9 million cancer cases from 2024 to 2033. Consequently, the escalating cancer burden is a key driver for the growth of the biomarker testing market.

How Are Different Segment Groups Identified Within The Biomarker Testing Market?

The biomarker testing market covered in this report is segmented –

1) By Product Type: Consumables, Instruments, Services

2) By Technology: Polymerase Chain Reaction, Next-Generation Sequencing, Immunoassays, Other Technologies

3) By Application: Oncology, Cardiology, Neurology, Infectious Diseases, Other Applications

4) By End-User: Hospitals, Diagnostic Laboratories, Research Institutes, Other End-Users

Subsegments:

1) By Consumables: Reagents, Assay Kits, Sample Collection Devices, Chemicals And Buffers

2) By Instruments: Polymerase Chain Reaction (PCR) Systems, Next-Generation Sequencing (NGS) Platforms, Microarray Systems, Mass Spectrometry Instruments, Immunoassay Analyzers

3) By Services: Biomarker Discovery Services, Diagnostic Testing Services, Companion Diagnostic Development, Clinical Trial Testing Services, Contract Research Organization (CRO) Services

Which Trends Are Contributing To Changes In The Biomarker Testing Market?

Major companies operating in the biomarker testing market are prioritizing the development of sophisticated solutions, such as immunohistochemistry (IHC) technology, to enhance diagnostic precision, enable prompt disease detection, and support individualized treatment plans. Immunohistochemistry (IHC) technology is a laboratory procedure that utilizes antibodies to identify specific proteins in tissue specimens, thereby facilitating the recognition and visualization of biomarkers for disease diagnosis and research. For example, in July 2023, Quest Diagnostics Incorporated, a US-based medical laboratories firm, introduced a new tissue-based prostate cancer biomarker test via its AmeriPath business, aiming to improve diagnostic accuracy with its proprietary biomarkers EV1, EV2, and EV3. This test fulfills a crucial clinical need by assisting physicians in more precisely identifying and differentiating aggressive forms of prostate cancer, enhancing grading consistency, and guiding appropriate treatment strategies for patients.

Who Are The Major Companies Operating In The Biomarker Testing Market?

Major companies operating in the biomarker testing market are Roche Diagnostics International Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers AG, Becton Dickinson and Company, GE HealthCare Technologies Inc., Agilent Technologies Inc., Illumina Inc., Hologic Inc., Charles River Laboratories International Inc., PerkinElmer Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., DiaSorin S.p.A., Myriad Genetics Inc., Guardant Health Inc., Sino Biological Inc., Proteome Sciences plc

Access The Complete Biomarker Testing Market Report:

https://www.thebusinessresearchcompany.com/report/biomarker-testing-global-market-report

Which Area Represents The Largest Portion Of The Biomarker Testing Market?

North America was the largest region in the biomarker testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biomarker testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Biomarker Testing Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=24480&type=smp

Browse Through More Reports Similar to the Global Biomarker Testing Market 2026, By The Business Research Company

Clinical Biomarkers Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-biomarkers-global-market-report

Biomarker Discovery Outsourcing Services Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/biomarker-discovery-outsourcing-services-global-market-report

Cancer Biomarker Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/cancer-biomarker-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Cosmetic Surgery Market Expected To Change From 2026 To 2030?

The cosmetic surgery market has experienced robust growth in recent years. Its size is anticipated to expand from $58.42 billion in 2025 to $63.22 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.2%. This historical growth can be ascribed to a heightened aesthetic awareness, an increase in disposable incomes, the considerable influence of media and celebrities, the expansion of private cosmetic clinics, and advancements in surgical safety standards.

The cosmetic surgery market is projected to experience substantial expansion in the coming years. This market is anticipated to reach $83.52 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.2%. Factors contributing to this growth over the forecast period include technological improvements in aesthetics, broader acceptance among various age demographics, the rise of medical tourism, a growing preference for non-invasive treatments, and the proliferation of outpatient cosmetic facilities. Key trends shaping the market during this period encompass an escalating demand for minimally invasive interventions, an increase in non-surgical aesthetic solutions, greater male involvement in cosmetic procedures, the widening network of medical aesthetic clinics, and an emphasis on achieving natural and customized results.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/cosmetic-surgery-global-market-report

What Key Factors Are Shaping The Cosmetic Surgery Market Landscape?

The increasing volume of aesthetic procedures is anticipated to fuel the expansion of the cosmetic surgery market in the future. These procedures encompass cosmetic treatments designed to improve an individual’s look, frequently involving either surgical or non-surgical methods. This growth in aesthetic procedures stems from increasing consumer desire for beauty improvements, technological progress, and a greater emphasis on self-care and personal aesthetics. Aesthetic procedures not only streamline and enhance an individual’s personal appearance but also contribute to increased confidence, encourage self-care practices, and effectively resolve particular cosmetic issues. For example, in June 2024, data from the American Society of Plastic Surgeons, a US-based non-profit organization, revealed that in 2023, a total of 347,782 liposuction procedures were carried out, marking a 7% increase compared to 2022. Throughout that year, minimally invasive procedures also saw a 7% rise, surpassing the growth rate of surgical procedures by 2 percentage points. In general, plastic surgeries experienced a 5% year-over-year increase, concurrent with a 7% rise in minimally invasive treatments. Consequently, the growing prevalence of aesthetic procedures is set to propel the expansion of the cosmetic surgery market.

What Segment Categories Shape The Cosmetic Surgery Market Segment Landscape?

The cosmetic surgery market covered in this report is segmented –

1) By Procedure Type: Surgical Procedures, Non-Surgical Procedures, Other Procedures

2) By Provider: Spas And Cosmetic Surgery Centers, Hospitals And Specialty Clinics

3) By Gender: Male, Female

4) By Application: Liposuction, Eyelid And Nose Surgery, Body Contouring, Face Reconstruction, Cosmetic Implants, Other Applications

5) By End-User: Hospitals, Surgical Centers, Other End-Users

Subsegments:

1) By Surgical Procedures: Breast Augmentation, Liposuction, Rhinoplasty (Nose Surgery), Facelift Surgery (Rhytidectomy), Eyelid Surgery (Blepharoplasty), Tummy Tuck (Abdominoplasty), Chin And Cheek Surgery, Hair Transplant Surgery, Other Surgical Procedures

2) By Non-Surgical Procedures: Botox Injections, Dermal Fillers (Hyaluronic Acid Fillers), Chemical Peels, Laser Hair Removal, Microdermabrasion, Non-Surgical Facelift (Thread Lift), Cryolipolysis (Fat Freezing), Platelet-Rich Plasma (PRP) Therapy, Other Non-Surgical Procedures

3) By Other Procedures: Body Contouring (CoolSculpting, Radiofrequency), Scalp Micropigmentation, Tattoo Removal, Skin Rejuvenation Treatments (LED Therapy, Microneedling)

What Market Trends Are Affecting The Cosmetic Surgery Market?

Leading companies operating within the cosmetic surgery market are increasingly concentrating on developing inventive solutions, such as perioperative recovery devices, to satisfy growing patient expectations for quicker healing, reduced recovery periods, and superior post-surgical outcomes. These non-invasive medical technologies are engineered to enhance the body’s natural healing processes immediately before, during, and after surgical procedures. Unlike conventional recovery strategies that primarily rely on pharmaceutical pain management and rest, these advanced systems employ proprietary protocols and technologies to expedite wound healing, reduce inflammation, and improve overall patient comfort. For instance, in August 2025, ELIXIR MD Inc., a US-based medical device company, introduced the ELIXIR MD device, following its establishment of a wholly owned subsidiary in Australia & New Zealand through an exclusive partnership with High Tech Medical Pty Ltd. The ELIXIR MD device, along with its proprietary perioperative treatment protocols, is FDA-cleared and specifically designed for facial surgery recovery. The underlying technology combines non-invasive electrical stimulation (or a similar modality) and bespoke clinical protocols to optimize the healing process: it aids in reducing swelling, minimizing bruising, and promoting faster tissue regeneration, thereby significantly decreasing patient downtime and enhancing surgical outcomes, which is a clear advancement over traditional recovery methods. Its distinctive attributes encompass customizable treatment regimens, compatibility with various facial surgical procedures (like facelifts or blepharoplasty), and integration into standard surgical workflows, rendering it exceptionally useful for aesthetic surgery clinics seeking to offer premium post-operative care.

Who Are The Companies Operating Across The Cosmetic Surgery Market Value Chain?

Major companies operating in the cosmetic surgery market are Polytech Health & Aesthetics GmbH, Galderma SA, Lumenis Ltd., Solta Medical Inc., Evolus Inc., Revance Therapeutics Inc., Syneron Candela Corporation, Alma Lasers Ltd., Sinclair Pharma plc, HansBiomed Co. Ltd., Teoxane Laboratories, Cynosure Inc., Merz Pharma GmbH & Co. KGaA, Vital Esthetique Inc., GC Aesthetics LLC, Cutera Inc., InMode Ltd., Sciton Inc., Suneva Medical Inc., Fotona, Sisram Med, El.En Group, Lutronic Corporation, Sofwave Medical Ltd.

Get The Full Cosmetic Surgery Market Report:

https://www.thebusinessresearchcompany.com/report/cosmetic-surgery-global-market-report

Which Region Leads The Cosmetic Surgery Market In Terms Of Market Share?

North America was the largest region in the cosmetic surgery market in 2025 and is expected to be the fastest-growing region in the forecast period. The regions covered in the cosmetic surgery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Cosmetic Surgery Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/cosmetic-surgery-global-market-report

Browse Through More Reports Similar to the Global Cosmetic Surgery Market 2026, By The Business Research Company

Hair Preparations Market Report 2026

https://www.thebusinessresearchcompany.com/report/hair-preparations-global-market-report

Cosmetic Implants Market Report 2026

https://www.thebusinessresearchcompany.com/report/cosmetic-implants-global-market-report

Cosmetic Dentistry Market Report 2026

https://www.thebusinessresearchcompany.com/report/cosmetic-dentistry-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Level Of Market Value Growth Is Predicted For The Biomarker Testing Market From 2026 To 2030?

The size of the biomarker testing market has experienced rapid expansion in recent years. This market is projected to increase from $19.75 billion in 2025 to $22.26 billion in 2026, registering a compound annual growth rate (CAGR) of 12.7%. The growth observed during the historic period was primarily driven by the increasing prevalence of chronic diseases, the expansion of clinical research activities, the rising adoption of molecular diagnostics, a growing demand for targeted therapies, and the availability of advanced testing platforms.

The biomarker testing market is projected to experience substantial expansion in the coming years, with its size anticipated to reach $35.51 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.4%. This growth in the forecast period is primarily driven by increasing investments in personalized medicine, the rising application of biomarkers in drug development, the expansion of oncology and infectious disease testing, the growing demand for minimally invasive diagnostics, and advancements in multi-omics technologies. Furthermore, major trends for this period include the increasing adoption of precision medicine diagnostics, the rising use of companion diagnostics, the growing integration of AI in biomarker analysis, the expansion of liquid biopsy testing, and an enhanced focus on early disease detection.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/biomarker-testing-global-market-report

What Major Factors Are Driving The Biomarker Testing Market Forward?

The escalating incidence of cancer is projected to fuel the expansion of the biomarker testing market in the future. Cancer refers to a collection of diseases characterized by the uncontrolled proliferation and dissemination of abnormal cells within the body. This growing cancer burden is attributed to lifestyle choices such as an unhealthy diet, smoking, insufficient physical activity, and excessive alcohol consumption. Biomarker testing enhances cancer detection by enabling early and precise identification of disease-specific markers, thus improving diagnostic accuracy. Additionally, it supports personalized treatment strategies, leading to better patient outcomes and more effective healthcare management. For instance, in July 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, approximately 165,000 new cancer cases were diagnosed in 2023, with projections indicating that around 204,000 cases will be diagnosed annually by 2033, contributing to an estimated total of 1.9 million cancer cases between 2024 and 2033. Consequently, the increasing prevalence of cancer is driving the growth of the biomarker testing market.

What Segment Categories Shape The Biomarker Testing Market Segment Landscape?

The biomarker testing market covered in this report is segmented –

1) By Product Type: Consumables, Instruments, Services

2) By Technology: Polymerase Chain Reaction, Next-Generation Sequencing, Immunoassays, Other Technologies

3) By Application: Oncology, Cardiology, Neurology, Infectious Diseases, Other Applications

4) By End-User: Hospitals, Diagnostic Laboratories, Research Institutes, Other End-Users

Subsegments:

1) By Consumables: Reagents, Assay Kits, Sample Collection Devices, Chemicals And Buffers

2) By Instruments: Polymerase Chain Reaction (PCR) Systems, Next-Generation Sequencing (NGS) Platforms, Microarray Systems, Mass Spectrometry Instruments, Immunoassay Analyzers

3) By Services: Biomarker Discovery Services, Diagnostic Testing Services, Companion Diagnostic Development, Clinical Trial Testing Services, Contract Research Organization (CRO) Services

Which Trends Are Impacting The Progress Of The Biomarker Testing Market?

Leading firms within the biomarker testing market are concentrating their efforts on creating sophisticated technological solutions, including immunohistochemistry (IHC) technology, with the aim of boosting diagnostic precision, facilitating prompt disease identification, and aiding individualized treatment approaches. This immunohistochemistry (IHC) technology represents a laboratory method employing antibodies to locate particular proteins in tissue specimens, thereby assisting in the identification and visualization of biomarkers crucial for disease diagnosis and investigative purposes. As an example, in July 2023, Quest Diagnostics Incorporated, a medical laboratories firm situated in the US, introduced a novel tissue-based prostate cancer biomarker test via its AmeriPath division, designed to improve diagnostic exactness utilizing its unique biomarkers EV1, EV2, and EV3. The introduction of this test fulfills a vital clinical requirement by assisting medical professionals in more accurately identifying and distinguishing aggressive prostate cancer types, enhancing the uniformity of grading, and directing suitable treatment plans for individuals.

Who Are The Companies Operating Across The Biomarker Testing Market Value Chain?

Major companies operating in the biomarker testing market are Roche Diagnostics International Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers AG, Becton Dickinson and Company, GE HealthCare Technologies Inc., Agilent Technologies Inc., Illumina Inc., Hologic Inc., Charles River Laboratories International Inc., PerkinElmer Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., DiaSorin S.p.A., Myriad Genetics Inc., Guardant Health Inc., Sino Biological Inc., Proteome Sciences plc

Get The Full Biomarker Testing Market Report:

https://www.thebusinessresearchcompany.com/report/biomarker-testing-global-market-report

Which Region Leads The Biomarker Testing Market In Overall Market Size?

North America was the largest region in the biomarker testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biomarker testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Biomarker Testing Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/biomarker-testing-global-market-report

Browse Through More Reports Similar to the Global Biomarker Testing Market 2026, By The Business Research Company

Cancer Biomarker Market Report 2026

https://www.thebusinessresearchcompany.com/report/cancer-biomarker-global-market-report

Clinical Biomarkers Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-biomarkers-global-market-report

Biomarker Discovery Outsourcing Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/biomarker-discovery-outsourcing-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Level Of Market Value Growth Is Predicted For The Biomarker Testing Market From 2026 To 2030?

The size of the biomarker testing market has experienced rapid expansion in recent years. This market is projected to increase from $19.75 billion in 2025 to $22.26 billion in 2026, registering a compound annual growth rate (CAGR) of 12.7%. The growth observed during the historic period was primarily driven by the increasing prevalence of chronic diseases, the expansion of clinical research activities, the rising adoption of molecular diagnostics, a growing demand for targeted therapies, and the availability of advanced testing platforms.

The biomarker testing market is projected to experience substantial expansion in the coming years, with its size anticipated to reach $35.51 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.4%. This growth in the forecast period is primarily driven by increasing investments in personalized medicine, the rising application of biomarkers in drug development, the expansion of oncology and infectious disease testing, the growing demand for minimally invasive diagnostics, and advancements in multi-omics technologies. Furthermore, major trends for this period include the increasing adoption of precision medicine diagnostics, the rising use of companion diagnostics, the growing integration of AI in biomarker analysis, the expansion of liquid biopsy testing, and an enhanced focus on early disease detection.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/biomarker-testing-global-market-report

What Major Factors Are Driving The Biomarker Testing Market Forward?

The escalating incidence of cancer is projected to fuel the expansion of the biomarker testing market in the future. Cancer refers to a collection of diseases characterized by the uncontrolled proliferation and dissemination of abnormal cells within the body. This growing cancer burden is attributed to lifestyle choices such as an unhealthy diet, smoking, insufficient physical activity, and excessive alcohol consumption. Biomarker testing enhances cancer detection by enabling early and precise identification of disease-specific markers, thus improving diagnostic accuracy. Additionally, it supports personalized treatment strategies, leading to better patient outcomes and more effective healthcare management. For instance, in July 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, approximately 165,000 new cancer cases were diagnosed in 2023, with projections indicating that around 204,000 cases will be diagnosed annually by 2033, contributing to an estimated total of 1.9 million cancer cases between 2024 and 2033. Consequently, the increasing prevalence of cancer is driving the growth of the biomarker testing market.

What Segment Categories Shape The Biomarker Testing Market Segment Landscape?

The biomarker testing market covered in this report is segmented –

1) By Product Type: Consumables, Instruments, Services

2) By Technology: Polymerase Chain Reaction, Next-Generation Sequencing, Immunoassays, Other Technologies

3) By Application: Oncology, Cardiology, Neurology, Infectious Diseases, Other Applications

4) By End-User: Hospitals, Diagnostic Laboratories, Research Institutes, Other End-Users

Subsegments:

1) By Consumables: Reagents, Assay Kits, Sample Collection Devices, Chemicals And Buffers

2) By Instruments: Polymerase Chain Reaction (PCR) Systems, Next-Generation Sequencing (NGS) Platforms, Microarray Systems, Mass Spectrometry Instruments, Immunoassay Analyzers

3) By Services: Biomarker Discovery Services, Diagnostic Testing Services, Companion Diagnostic Development, Clinical Trial Testing Services, Contract Research Organization (CRO) Services

Which Trends Are Impacting The Progress Of The Biomarker Testing Market?

Leading firms within the biomarker testing market are concentrating their efforts on creating sophisticated technological solutions, including immunohistochemistry (IHC) technology, with the aim of boosting diagnostic precision, facilitating prompt disease identification, and aiding individualized treatment approaches. This immunohistochemistry (IHC) technology represents a laboratory method employing antibodies to locate particular proteins in tissue specimens, thereby assisting in the identification and visualization of biomarkers crucial for disease diagnosis and investigative purposes. As an example, in July 2023, Quest Diagnostics Incorporated, a medical laboratories firm situated in the US, introduced a novel tissue-based prostate cancer biomarker test via its AmeriPath division, designed to improve diagnostic exactness utilizing its unique biomarkers EV1, EV2, and EV3. The introduction of this test fulfills a vital clinical requirement by assisting medical professionals in more accurately identifying and distinguishing aggressive prostate cancer types, enhancing the uniformity of grading, and directing suitable treatment plans for individuals.

Who Are The Companies Operating Across The Biomarker Testing Market Value Chain?

Major companies operating in the biomarker testing market are Roche Diagnostics International Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers AG, Becton Dickinson and Company, GE HealthCare Technologies Inc., Agilent Technologies Inc., Illumina Inc., Hologic Inc., Charles River Laboratories International Inc., PerkinElmer Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., DiaSorin S.p.A., Myriad Genetics Inc., Guardant Health Inc., Sino Biological Inc., Proteome Sciences plc

Get The Full Biomarker Testing Market Report:

https://www.thebusinessresearchcompany.com/report/biomarker-testing-global-market-report

Which Region Leads The Biomarker Testing Market In Overall Market Size?

North America was the largest region in the biomarker testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biomarker testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Biomarker Testing Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/biomarker-testing-global-market-report

Browse Through More Reports Similar to the Global Biomarker Testing Market 2026, By The Business Research Company

Cancer Biomarker Market Report 2026

https://www.thebusinessresearchcompany.com/report/cancer-biomarker-global-market-report

Clinical Biomarkers Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-biomarkers-global-market-report

Biomarker Discovery Outsourcing Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/biomarker-discovery-outsourcing-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Growth Is Projected For The Biomarker Testing Market During The Forecast Period 2026–2030?

The biomarker testing market has experienced significant expansion in recent years. It is forecast to increase from $19.75 billion in 2025 to $22.26 billion in 2026, progressing at a compound annual growth rate (CAGR) of 12.7%. This historic growth can be linked to factors such as the rising incidence of chronic diseases, the expansion of clinical research, the increasing adoption of molecular diagnostics, the growing requirement for targeted therapies, and the availability of advanced testing platforms.

The biomarker testing market size is projected to experience swift expansion in the coming years. This market is set to reach $35.51 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.4%. The anticipated growth during this period stems from factors such as increased investments in personalized medicine, a greater application of biomarkers in drug development, the broadening scope of oncology and infectious disease testing, an increasing need for minimally invasive diagnostics, and breakthroughs in multi-omics technologies. Key developments expected during the forecast period involve a greater uptake of precision medicine diagnostics, an increasing reliance on companion diagnostics, the expanding integration of AI into biomarker analysis, the growth of liquid biopsy testing, and an intensified emphasis on detecting diseases early.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24480&type=smp

What Drivers Are Expected To Influence The Biomarker Testing Market During The Forecast Period?

The increasing incidence of cancer is anticipated to stimulate expansion within the biomarker testing market. Cancer is defined as a collection of illnesses marked by the unregulated proliferation and dissemination of abnormal cells throughout the body. The escalating prevalence of cancer stems from lifestyle factors such as inadequate nutrition, tobacco use, insufficient physical activity, and excessive alcohol intake. Biomarker testing improves cancer detection through the early and accurate identification of disease-specific indicators, thereby enhancing diagnostic precision. It also facilitates tailored treatment strategies, resulting in superior patient results and more efficient healthcare administration. As an illustration, in July 2024, the Australian Institute of Health and Welfare, an Australia-based government agency, reported approximately 165,000 new cancer cases diagnosed in 2023, with forecasts suggesting about 204,000 cases will be diagnosed annually by 2033, culminating in an estimated aggregate of 1.9 million cancer cases between 2024 and 2033. Consequently, the growing cancer burden is fueling the expansion of the biomarker testing market.

What Market Segments Are Evaluated Within The Biomarker Testing Market?

The biomarker testing market covered in this report is segmented –

1) By Product Type: Consumables, Instruments, Services

2) By Technology: Polymerase Chain Reaction, Next-Generation Sequencing, Immunoassays, Other Technologies

3) By Application: Oncology, Cardiology, Neurology, Infectious Diseases, Other Applications

4) By End-User: Hospitals, Diagnostic Laboratories, Research Institutes, Other End-Users

Subsegments:

1) By Consumables: Reagents, Assay Kits, Sample Collection Devices, Chemicals And Buffers

2) By Instruments: Polymerase Chain Reaction (PCR) Systems, Next-Generation Sequencing (NGS) Platforms, Microarray Systems, Mass Spectrometry Instruments, Immunoassay Analyzers

3) By Services: Biomarker Discovery Services, Diagnostic Testing Services, Companion Diagnostic Development, Clinical Trial Testing Services, Contract Research Organization (CRO) Services

What Major Market Trends Are Driving Changes In The Biomarker Testing Market?

Major companies operating in the biomarker testing market are prioritizing the development of advanced technological solutions, such as immunohistochemistry (IHC) technology, to enhance diagnostic precision, enable early disease detection, and support individualized treatment plans. Immunohistochemistry (IHC) technology is a laboratory procedure that employs antibodies to pinpoint specific proteins in tissue samples, thereby aiding in the identification and visualization of biomarkers for disease diagnosis and research. For instance, in July 2023, Quest Diagnostics Incorporated, a US-based medical laboratories company, launched a novel tissue-based prostate cancer biomarker test through its AmeriPath business, aiming to improve diagnostic accuracy using its proprietary biomarkers EV1, EV2, and EV3. This test fulfills a significant clinical need by helping physicians more accurately identify and differentiate aggressive forms of prostate cancer, leading to improved grading consistency and informing appropriate treatment strategies for patients.

Who Are The Top Market Participants Influencing The Biomarker Testing Market?

Major companies operating in the biomarker testing market are Roche Diagnostics International Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers AG, Becton Dickinson and Company, GE HealthCare Technologies Inc., Agilent Technologies Inc., Illumina Inc., Hologic Inc., Charles River Laboratories International Inc., PerkinElmer Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., DiaSorin S.p.A., Myriad Genetics Inc., Guardant Health Inc., Sino Biological Inc., Proteome Sciences plc

Read the full biomarker testing market report here:

https://www.thebusinessresearchcompany.com/report/biomarker-testing-global-market-report

Which Region Is Forecast To Lead The Biomarker Testing Market In Terms Of Market Size?

North America was the largest region in the biomarker testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biomarker testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Biomarker Testing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24480&type=smp

Browse Through More Reports Similar to the Global Biomarker Testing Market 2026, By The Business Research Company

Clinical Biomarkers Global Market Report

https://www.thebusinessresearchcompany.com/report/clinical-biomarkers-global-market-report

Biomarker Discovery Outsourcing Services Global Market Report

https://www.thebusinessresearchcompany.com/report/biomarker-discovery-outsourcing-services-global-market-report

Cancer Biomarker Global Market Report

https://www.thebusinessresearchcompany.com/report/cancer-biomarker-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model